DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

16 API Suppliers, 8 USDMF, 2 EU WC, 1 KDMF, 3 NDC API, 9 Listed Suppliers, $ API Reference Price

16 API Suppliers
8 USDMF
2 EU WC
1 KDMF
3 NDC API
9 Listed Suppliers
$ API Reference Price

INTERMEDIATES

3 Intermediates Suppliers

3 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

18 FDF Dossiers, 10 FDA Orange Book, 6 Europe, 2 Listed Dossiers

18 FDF Dossiers
10 FDA Orange Book
6 Europe
2 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

GEL;TOPICAL - 1%, CREAM;TOPICAL - 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 2%, GEL;TOPICAL - 2%

drugProductComposition
GEL;TOPICAL - 1%
CREAM;TOPICAL - 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CREAM;TOPICAL - 2%
GEL;TOPICAL - 2%

RELATED EXCIPIENT COMPANIES

4 DKSH, 6 Nanjing Well Pharmaceutical, 4 Actylis, 8 BASF, 1 Corel Pharma Chem, 2 Finar, 5 Gangwal Chemicals, 2 Lubrizol Life Science Health, 1 Microlex e.U, 1 Nanjing Bold Chemical, 10 Seppic, 1 Valens Pharmachem

relatedExcipients
4 DKSH
6 Nanjing Well Pharmaceutical
4 Actylis
8 BASF
1 Corel Pharma Chem
2 Finar
5 Gangwal Chemicals
2 Lubrizol Life Science Health
1 Microlex e.U
1 Nanjing Bold Chemical
10 Seppic
1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

24 Topical, 22 Solubilizers, 10 Emulsifying Agents, 10 Thickeners and Stabilizers, 10 Parenteral, 8 Surfactant & Foaming Agents, 5 Rheology Modifiers, 4 Film Formers & Plasticizers, 2 Direct Compression, 1 API Stability Enhancers, 1 Controlled & Modified Release, 1 Granulation, 1 Lubricants & Glidants, 1 Co-Processed Excipients

excipientsByApplications
24 Topical
22 Solubilizers
10 Emulsifying Agents
10 Thickeners and Stabilizers
10 Parenteral
8 Surfactant & Foaming Agents
5 Rheology Modifiers
4 Film Formers & Plasticizers
2 Direct Compression
1 API Stability Enhancers
1 Controlled & Modified Release
1 Granulation
1 Lubricants & Glidants
1 Co-Processed Excipients

DIGITAL CONTENT

3 NEWS #PharmaBuzz

media
3 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 7 Finished Drug Prices

globalSalesInformation
2 US Medicaid Prescriptions
7 Finished Drug Prices

MARKET PLACE

15 APIs

marketPlace
15 APIs

PATENTS & EXCLUSIVITIES

6 US Patents

patents
6 US Patents

REF. STANDARDS & IMPURITIES

1 USP , 1 Others

otherSolutions
1 USP
1 Others

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 411

MARKET PLACE

API

FDF

3INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

10,129,720

Annual Reports (USD Million)

Finished Drug Prices

45 RELATED EXCIPIENT COMPANIES

100EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 65473-14-5, Naftifine hcl, Naftin, Exoderil, Naftifungin, Naftifine, hcl

Molecular Formula

C₂₁H₂₂ClN

Molecular Weight

323.9 g/mol

InChI Key

OLUNPKFOFGZHRT-YGCVIUNWSA-N

FDA UNII

25UR9N9041

Naftifine Hydrochloride is the hydrochloride salt form of naftifine, an allylamine derivate with synthetic broad-spectrum antifungal activity. Although the exact mechanism through which naftifine hydrochloride exerts its effect is unknown, it appears to selectively inhibit the enzyme squalene 2,3-epoxidase, thereby inhibiting the biosynthesis of sterol. This results in a decreased amount of sterols, especially ergosterol which is the primary fungal membrane sterol, and a corresponding accumulation of squalene in fungal cells. Naftifine hydrochloride can be fungicidal as well as fungistatic to yeasts depending on the concentration and the organisms involved.

1 2D Structure

NAFTIFINE HCL

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(E)-N-methyl-N-(naphthalen-1-ylmethyl)-3-phenylprop-2-en-1-amine;hydrochloride

2.1.2 InChI

InChI=1S/C21H21N.ClH/c1-22(16-8-11-18-9-3-2-4-10-18)17-20-14-7-13-19-12-5-6-15-21(19)20;/h2-15H,16-17H2,1H3;1H/b11-8+;

2.1.3 InChI Key

OLUNPKFOFGZHRT-YGCVIUNWSA-N

2.1.4 Canonical SMILES

CN(CC=CC1=CC=CC=C1)CC2=CC=CC3=CC=CC=C32.Cl

2.1.5 Isomeric SMILES

CN(C/C=C/C1=CC=CC=C1)CC2=CC=CC3=CC=CC=C32.Cl

2.2 Other Identifiers

2.2.1 UNII

25UR9N9041

2.3 Synonyms

2.3.1 MeSH Synonyms

1. N-cinnamyl-n-methyl-1-naphthalenemethylamine Hydrochloride

2. Naftifin

3. Naftifine

4. Naftifine Hydrochloride, (e)-isomer

2.3.2 Depositor-Supplied Synonyms

1. 65473-14-5

2. Naftifine Hcl

3. Naftin

4. Exoderil

5. Naftifungin

6. Naftifine, Hcl

7. Aw 105-843

8. Naftifine (hydrochloride)

9. (e)-n-methyl-n-(naphthalen-1-ylmethyl)-3-phenylprop-2-en-1-amine Hydrochloride

10. Aw 105843

11. Nsc-760068

12. Naft900

13. Chebi:7452

14. Naft-900

15. Naftifin

16. 25ur9n9041

17. N-trans-cinnamyl-n-methyl-(1-naphthylmethyl)amine Hydrochloride

18. Dsstox_cid_25496

19. Dsstox_rid_80915

20. Dsstox_gsid_45496

21. Aw-105-843

22. 65473-14-5 (hcl); 65472-88-0 (free Base).

23. (e)-n-methyl-n-(naphthalen-1-ylmethyl)-3-phenylprop-2-en-1-amine;hydrochloride

24. Naftifinehydrochloride

25. Naftifine Hydrochloride [usan]

26. Suadian

27. Sn 105843

28. Unii-25ur9n9041

29. (e)-naftifine

30. Naftin Hydrochloride

31. Naftifine Hydrochloride [usan:usp]

32. Mfcd00059047

33. Naftin (tn)

34. (e)-n-methyl-n-(1-naphthylmethyl)-3-phenyl-prop-2-en-1-amine

35. (e)-n-cinnamyl-n-methyl-1-naphthalenemethylamine Hydrochloride

36. Ncgc00016908-01

37. (e)-n-methyl-n-(1-naphthylmethyl)-3-phenyl-2-propen-1-amine- Hydrochloride

38. Cas-65473-14-5

39. Surecn1649698

40. Schembl41356

41. Mls002154136

42. Naftifine Hydrochloride ,(s)

43. Naftifine Hydrochloride (usp)

44. Naft-600

45. Schembl4932462

46. Chembl1200493

47. Dtxsid2045496

48. Hy-b0518a

49. Hms1571e08

50. Pharmakon1600-01505446

51. Bcp07446

52. Naftifine Hydrochloride [mi]

53. Tox21_110677

54. Nsc760068

55. S3156

56. Akos015895211

57. Tox21_110677_1

58. Ac-1120

59. Ccg-213447

60. H72n880

61. Naftifine Hydrochloride [mart.]

62. Naftifine Hydrochloride [vandf]

63. Nsc 760068

64. 1-naphthalenemethanamine, N-methyl-n-(3-phenyl-2-propenyl)-, Hydrochloride, (e)-

65. 1-naphthalenemethanamine, N-methyl-n-[(2e)-3-phenyl-2-propenyl]-,hydrochloride

66. Naftifine Hydrochloride [usp-rs]

67. Naftifine Hydrochloride [who-dd]

68. Ncgc00179332-03

69. As-13296

70. Smr001233443

71. Sn-105843

72. C1162

73. Naftifine Hydrochloride [orange Book]

74. Naftifine Hydrochloride [usp Impurity]

75. C08072

76. D00883

77. Naftifine Hydrochloride [usp Monograph]

78. A835130

79. Sr-01000838853

80. Sr-01000838853-2

81. Naftifine Hydrochloride 100 Microg/ml In Acetonitrile

82. Q27107497

83. (e)-n-cinnamyl-n-methyl(1-naphthylmethyl)amine Hydrochloride

84. N-methyl-n-(naphthalen-1-ylmethyl)-3-phenylprop-2-en-1-amine Hydrochloride

85. Naftifine Hydrochloride, United States Pharmacopeia (usp) Reference Standard

86. (e)-n-methyl-n-(1-naphthalenylmethyl)-3-phenyl-2-propen-1-amine Hydrochloride

87. (e)-n-methyl-n-(3-phenyl-2-propenyl)-1-naphthalenemethanamine Hydrochloride

88. (e)-n-methyl-n-(naphthalen-1-ylmethyl)-3-phenyl-prop-2-en-1-amine Hydrochloride

2.4 Create Date

2005-06-24

3 Chemical and Physical Properties

Molecular Formula	C₂₁H₂₂ClN
Molecular Weight	323.9 g/mol
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	1
Rotatable Bond Count	5
Exact Mass	323.1440774 g/mol
Monoisotopic Mass	323.1440774 g/mol
Topological Polar Surface Area	3.2 Å²
Heavy Atom Count	23
Formal Charge	0
Complexity	342
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	1
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2

4 Drug and Medication Information

4.1 Drug Information

1 of 2
Drug Name	Naftin
PubMed Health	Naftifine (On the skin)
Drug Classes	Antifungal
Drug Label	Naftin Cream, 1% contains the synthetic, broad-spectrum, antifungal agent naftifine hydrochloride. Naftin Cream, 1% is for topical use only....
Active Ingredient	Naftifine hydrochloride
Dosage Form	Cream; Gel
Route	Topical
Strength	1%; 2%
Market Status	Prescription
Company	Merz Pharms

2 of 2
Drug Name	Naftin
PubMed Health	Naftifine (On the skin)
Drug Classes	Antifungal
Drug Label	Naftin Cream, 1% contains the synthetic, broad-spectrum, antifungal agent naftifine hydrochloride. Naftin Cream, 1% is for topical use only....
Active Ingredient	Naftifine hydrochloride
Dosage Form	Cream; Gel
Route	Topical
Strength	1%; 2%
Market Status	Prescription
Company	Merz Pharms

5 Pharmacology and Biochemistry

5.1 MeSH Pharmacological Classification

Antifungal Agents

Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)

5.2 FDA Pharmacological Classification

5.2.1 Pharmacological Classes

Allylamine [CS]; Allylamine Antifungal [EPC]

API SUPPLIERS

01

HRV Global Life Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering

Not Confirmed

HRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.

Contact Supplier

India

Virtual Booth

Digital Content

USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT

02

MSN Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering

Not Confirmed

03

Taro Pharmaceutical Industries

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering

Not Confirmed

04

Sifavitor srl

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering

Not Confirmed

05

Novartis Pharmaceuticals Corporati...

Switzerland

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering

Not Confirmed

06

Shanghai Ziyuan Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering

Not Confirmed

07

Chongqing Huapont Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering

Not Confirmed

08

Erregierre SpA

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering

Not Confirmed

09

Sandoz B2B

Switzerland

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering

Not Confirmed

10

Global Calcium

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering

Not Confirmed

Only 10 entries up to this point, click to access all

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KDMF

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

01

HRV Global Life Sciences

India

Antibody Engineering

Not Confirmed

HRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.

Contact Supplier

India

Virtual Booth

Digital Content

NAFTIFINE HCL

About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...

HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It offers services such as sourcing, manufacturing & supply, helping partners enter new markets worldwide. Its strong partnerships with major players in the pharma and food additive industries help HRV Global effectively promote projects and products. HRV Global represents over 30 large Indian drugmakers, primarily targeting Europe, the US & the Middle East markets. Headquartered in India, HRV Global has offices in the US, Switzerland, Dubai, Lithuania & Turkey.

02

Allastir

India

Antibody Engineering

Not Confirmed

03

Chongqing Huapont Pharmaceutical

China

Antibody Engineering

Not Confirmed

04

Erregierre SpA

Italy

Antibody Engineering

Not Confirmed

05

Farmak JSC

Ukraine

Antibody Engineering

Not Confirmed

06

Global Calcium

India

Antibody Engineering

Not Confirmed

07

Lusochimica

Italy

Antibody Engineering

Not Confirmed

08

Olon S.p.A

Italy

Antibody Engineering

Not Confirmed

09

Synergene Active Ingredients Pvt Lt...

India

Antibody Engineering

Not Confirmed

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

INTERMEDIATES SUPPLIERS

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Dossiers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - GEL;TOPICAL - 1%

USFDA APPLICATION NUMBER - 19356

DOSAGE - CREAM;TOPICAL - 1% **Federal Registe...DOSAGE - CREAM;TOPICAL - 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 19599

DOSAGE - CREAM;TOPICAL - 2%

USFDA APPLICATION NUMBER - 19599

DOSAGE - GEL;TOPICAL - 2%

USFDA APPLICATION NUMBER - 204286

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Topical

Solubilizers

Emulsifying Agents

Thickeners and Stabilizers

Parenteral

Surfactant & Foaming Agents

Rheology Modifiers

Film Formers & Plasticizers

Direct Compression

API Stability Enhancers

Controlled & Modified Release

Granulation

Lubricants & Glidants

Co-Processed Excipients

Digital Content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

Global Sales Information

Do you need Business Intel? Ask us

US Medicaid Prescriptions

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Finished Drug Prices

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

APIs

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

US Patents

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

USP

Others

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Find NAFTIFINE HCL manufacturers, exporters & distributors on PharmaCompass

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

16 API Suppliers

8 USDMF

2 EU WC

1 KDMF

3 NDC API

9 Listed Suppliers

$ API Reference Price

INTERMEDIATES

3 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

18 FDF Dossiers

10 FDA Orange Book

6 Europe

2 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

GEL;TOPICAL - 1%

CREAM;TOPICAL - 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - 2%

GEL;TOPICAL - 2%

RELATED EXCIPIENT COMPANIES

4 DKSH

6 Nanjing Well Pharmaceutical

4 Actylis

8 BASF

1 Corel Pharma Chem

2 Finar

5 Gangwal Chemicals

2 Lubrizol Life Science Health

1 Microlex e.U

1 Nanjing Bold Chemical

10 Seppic

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

24 Topical

22 Solubilizers

10 Emulsifying Agents

10 Thickeners and Stabilizers

10 Parenteral

8 Surfactant & Foaming Agents

5 Rheology Modifiers

4 Film Formers & Plasticizers

2 Direct Compression

1 API Stability Enhancers

1 Controlled & Modified Release

1 Granulation

1 Lubricants & Glidants

1 Co-Processed Excipients

DIGITAL CONTENT

3 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions

7 Finished Drug Prices

MARKET PLACE

15 APIs

PATENTS & EXCLUSIVITIES

6 US Patents

REF. STANDARDS & IMPURITIES

1 USP

1 Others

ACTIVE PHARMA INGREDIENTS

API REF. PRICE (USD/KG)

$ 411

MARKET PLACE

FINISHED DOSAGE FORMULATIONS

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

GLOBAL SALES INFORMATION

100EXCIPIENTS BY APPLICATIONS

01

02

03

CREAM;TOPICAL - 1% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons